Since its inception, SAA has been committed to research, from funding scientific meetings to launching the first genetic research study in the United States on ankylosing spondylitis and related diseases. Our commitment remains strong, as we have recently funded a patient registry, and a study on the microbiome in spondyloarthritis, as well as an educational MRI (magnetic resonance imaging) program to help radiologists and rheumatologists work together to hasten diagnosis.
SAA receives no government funding and relies on the
generous donations from individuals to create and maintain the programs and
services aimed at improving the futures of the 2.7 million Americans affected
SAA prides itself on being a leader in Spondylitis support. In addition to providing grants and spreading awareness, we sponsor a number of research programs that aim to find a cure for spondylitis.
As we seek to expand the number of rheumatologists and researchers in the United States focusing on spondyloarthritis, the Spondylitis Association of America has created the SAA/Bruckel Early Career Investigator Award hopes to encourage new, upcoming rheumatologists to focus on the future of treatment and research in ankylosing spondylitis and related diseases.
Health research has high value to society. It can provide important information about disease trends and risk factors, outcomes of treatment, functional abilities, patterns of care, and health care costs and use. The different approaches to research provide complementary insights. Clinical trials can provide important information about the efficacy and adverse effects of medical interventions by controlling the variables that could impact the results of the study, but feedback from real-world clinical experience is also crucial for comparing and improving the use of drugs, vaccines, medical devices, and diagnostics.
Click the button below to view some of the studies that have contributed to our increased understanding of spondyloarthritis.
16360 Roscoe Blvd. Ste. 100Van Nuys, CA 91406
(800) 777-8189 U.S. only
or (818) 892-1616